Monterey Bio Acquisition Corporation (MTRY)

NASDAQ: MTRY · IEX Real-Time Price · USD
10.02
0.00 (0.00%)
At close: Jun 22, 2022 12:00 AM
10.03
+0.01 (0.10%)
After-hours: Jun 23, 2022 4:00 PM EDT
0.00%
Market Cap 144.04M
Revenue (ttm) n/a
Net Income (ttm) -583,227
Shares Out 14.38M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 71
Open 10.02
Previous Close 10.02
Day's Range 10.02 - 10.02
52-Week Range 9.85 - 10.06
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About MTRY

Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York. [Read more...]

Industry Blank Check / SPAC
IPO Date Oct 1, 2021
Employees 2,021
Stock Exchange NASDAQ
Ticker Symbol MTRY
Full Company Profile

News

Monterey Bio Acquisition Corporation Announces the Separate Trading of its Common Stock and Warrants, Commencing Nove...

NEW YORK, Nov. 17, 2021 /PRNewswire/ -- Monterey Bio Acquisition Corporation (the "Company") announced today that, commencing November 22, 2021, holders of the units sold in the Company's initial public...

Monterey Bio Acquisition Corporation Announces Closing of Initial Public Offering and Full Exercise of Underwriter's ...

NEW YORK, Oct. 5, 2021 /PRNewswire/ -- Monterey Bio Acquisition Corporation ("Monterey Bio" or the "Company") (Nasdaq: MTRYU) today announced the closing of its previously announced initial public offer...